ArticleTheranostics2022

Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer.

Fang Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.